Patents by Inventor Nathan Teuscher

Nathan Teuscher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING VISUAL DISORDERS USING DAILY LOW DOSING OF A RETINOID COMPOUND
    Publication number: 20230321024
    Abstract: Provided herein are methods of treating a subject having a visual disorder comprising administering daily to the subject, a dosage of about 0.1 mg to 20 mg of a retinoid compound. In some embodiments, the retinoid compound is 9-cis-retinyl acetate.
    Type: Application
    Filed: June 8, 2021
    Publication date: October 12, 2023
    Inventors: Glenn NORONHA, Nathan TEUSCHER, Barrett KATZ
  • Effective dosing of a child for the treatment of ADHD with methylphenidate
    Patent number: 11166947
    Abstract: The present invention generally relates to treating attention-deficit disorders (e.g., ADHD) by providing an effective amount of an ADHD-effective agent to a patient in need thereof (e.g., a child).
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: November 9, 2021
    Assignee: Neos Therapeutics, LP
    Inventors: Mark Tengler, Nathan Teuscher
  • Effective Dosing of a Child for the Treatment of ADHD with Methylphenidate
    Publication number: 20190314356
    Abstract: The present invention generally relates to treating attention-deficit disorders (e.g., ADHD) by providing an effective amount of an ADHD-effective agent to a patient in need thereof (e.g., a child).
    Type: Application
    Filed: October 31, 2017
    Publication date: October 17, 2019
    Inventors: Mark TENGLER, Nathan TEUSCHER
  • Biomarker of improved intestinal function
    Publication number: 20070184554
    Abstract: The invention disclosed herein demonstrates that that the adaptive process in the intestine can be tracked using plasma citrulline. It further demonstrates that plasma citrulline is of clinical utility as a biomarker for improvements in intestinal function.
    Type: Application
    Filed: December 1, 2006
    Publication date: August 9, 2007
    Applicant: NPS ALLELIX CORP.
    Inventors: Nathan Teuscher, Lidia Demchyshyn, David Wells